FDA Inspection 1118372 — Thomas Jefferson University Hospital

Thomas Jefferson University Hospital — FEI 2572826

The FDA completed an inspection of Thomas Jefferson University Hospital on December 18, 2019 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 18, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Philadelphia, PA (United States)